Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pere Llinàs-Arias

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Open Biology|September 22, 2017
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an updatePere Llinàs-Arias, Manel Esteller
Hematological Oncology|February 20, 2020
Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research InstituteMaribel Parra, Maria Joao Baptista, Eulàlia Genescà, et al.
Clinical Epigenetics|August 1, 2021
Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncologyBorja Sesé, Miquel Ensenyat-Mendez, Sandra Iñiguez, et al.
JAMA Network Open|October 5, 2023
Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White FemalesMiquel Ensenyat-Mendez, Maria Solivellas-Pieras, Pere Llinàs-Arias, et al.
Research Square|November 24, 2025
Epigenetic programs shaping lung metastasis in triple-negative breast cancerDiego Marzese, Andres Bedoya-Lopez, Javier Orozco, et al.
Frontiers in Oncology|July 5, 2021
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast CancerMiquel Ensenyat-Mendez, Pere Llinàs-Arias, Javier I J Orozco, et al.
Cancers|August 27, 2021
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast CancerPere Llinàs-Arias, Sandra Íñiguez-Muñoz, Kelly McCann, et al.
Cancers|May 14, 2022
Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive PhenotypeBorja Sesé, Sandra Íñiguez-Muñoz, Miquel Ensenyat-Mendez, et al.
Cancer Letters|January 25, 2019
Germline variation in O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancerSami Belhadj, Cátia Moutinho, Pilar Mur, et al.
Oncotarget|September 9, 2017
Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancerMontserrat Pérez-Salvia, Laia Simó-Riudalbas, Pere Llinàs-Arias, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Open Biology|September 22, 2017
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an updatePere Llinàs-Arias, Manel Esteller
Hematological Oncology|February 20, 2020
Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research InstituteMaribel Parra, Maria Joao Baptista, Eulàlia Genescà, et al.
Clinical Epigenetics|August 1, 2021
Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncologyBorja Sesé, Miquel Ensenyat-Mendez, Sandra Iñiguez, et al.
JAMA Network Open|October 5, 2023
Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White FemalesMiquel Ensenyat-Mendez, Maria Solivellas-Pieras, Pere Llinàs-Arias, et al.
Research Square|November 24, 2025
Epigenetic programs shaping lung metastasis in triple-negative breast cancerDiego Marzese, Andres Bedoya-Lopez, Javier Orozco, et al.
Frontiers in Oncology|July 5, 2021
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast CancerMiquel Ensenyat-Mendez, Pere Llinàs-Arias, Javier I J Orozco, et al.
Cancers|August 27, 2021
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast CancerPere Llinàs-Arias, Sandra Íñiguez-Muñoz, Kelly McCann, et al.
Cancers|May 14, 2022
Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive PhenotypeBorja Sesé, Sandra Íñiguez-Muñoz, Miquel Ensenyat-Mendez, et al.
Cancer Letters|January 25, 2019
Germline variation in O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancerSami Belhadj, Cátia Moutinho, Pilar Mur, et al.
Oncotarget|September 9, 2017
Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancerMontserrat Pérez-Salvia, Laia Simó-Riudalbas, Pere Llinàs-Arias, et al.
Pageof 2